Citation Impact
Citing Papers
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease
1999 Standout
AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
1996 Standout
Nasopharyngeal carcinoma
2005 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Myasthenia Gravis
2016 Standout
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Manipulating the Immune System with Immune Globulin
1992
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Plasma Exchange in Children With Hemolytic-Uremic Syndrome at Risk of Poor Outcome
1993
The Emerging Role of Recombinant-Activated Factor VII in Neurocritical Care
2004
Guillain-Barré syndrome
2016 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Efficacy and safety of activated recombinant factor VII in cardiac surgical patients
2009
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
The 8p11 Myeloproliferative Syndrome: A Distinct Clinical Entity Caused by Constitutive Activation of <i>FGFR1</i>
2002
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
Clinical characteristics of antiphospholipid antibody syndrome in children
1996
Myasthenia Gravis
1994 Standout
Ondansetron versus Chlorpromazine for Preventing Emesis in Bone Marrow Transplant Recipients: a Double-Blind Randomized Study
1993
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
2005 Standout
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
Immune Thrombocytopenic Purpura
2002 Standout
Adults with Cyanotic Congenital Heart Disease: Hematologic Management
1988
Graft-versus-host disease
2009 Standout
Cerebral Sinovenous Thrombosis in Children
2001 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Noncardiac surgery in Eisenmenger syndrome
1999
Lessons learned in the management of hemolytic uremic syndrome in children
1995
Myasthenia gravis: management issues during pregnancy
2005
Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor
1996 Standout
Neuroblastoma
2007 Standout
Childhood Leukemias
1995
Radiation injury and neurogenesis
2003
Radiation Dose–Volume Effects in the Heart
2010
Disease Outcome May Be Predicted by Molecular Detection of Minimal Residual Disease in Bone Marrow in Advanced Neuroblastoma: A Pilot Study
2001
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
Disseminated Intravascular Coagulation
1999 Standout
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
1991 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Late effects of childhood cancer therapy
2002
A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis
1993 Standout
The immunopathogenesis of sepsis
2002 StandoutNature
Studies of β-thromboglobulin, platelet factor 4, and fibrinopeptide a in erythrocytosis due to cyanotic congenital heart disease
1983
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
1984 Standout
Virus-associated hemophagocytic syndromeA benign histiocytic proliferation distinct from malignant histiocytosis
1979 Standout
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation
1986 Standout
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Pregnancy-associated thrombocytopenia: pathogenesis and management
1992
Bone Marrow Transplants from HLA-Identical Siblings as Compared with Chemotherapy for Children with Acute Lymphoblastic Leukemia in a Second Remission
1994
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
1979 Standout
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
2003 StandoutScience
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
1999
Aspirin and dipyridamole therapy in the hemolytic-uremic syndrome
1980
Partial NH2- and cooh-terminal sequence analyses of Eco RI DNA restriction and modification enzymes.
1981 StandoutNobel
Clonal origin of the Philadelphia translocation in chronic myeloid leukemia demonstrated in somatic cell hybrids using an adenylate kinase-1 polymorphism
1982
Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease
2013
Coagulation findings in the hemolytic-uremic syndrome of infancy: Similarity to hyperacute renal allograft rejection
1971
Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage
1977
The pathogenesis of cancer metastasis
1980 StandoutNature
Granulocyte Colony-Stimulating Factor Reduces the Capacity of Blood Mononuclear Cells to Induce Graft-Versus-Host Disease: Impact on Blood Progenitor Cell Transplantation
1997
A Study of Occupational Exposure to Antineoplastic Drugs and Fetal Loss in Nurses
1985 Standout
Disappearance of pH1-Positive Cells in Four Patients with Chronic Granulocytic Leukemia after Chemotherapy, Irradiation and Marrow Transplantation from an Identical Twin
1979 StandoutNobel
Radiation injury and neurogenesis
2003
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Progress of Memory Function After Radiation Therapy in Patients With Nasopharyngeal Carcinoma
2003
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Toxicity of Antineoplastic Agents in Man: Chromosomal Aberrations, Antifertility Effects, Congenital Malformations, and Carcinogenic Potential
1976
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Development of Large Scale Fractionation Methods
1979
Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia.
1983
The Anthracycline Antineoplastic Drugs
1981 Standout
The Pathogenesis of Atherosclerosis
1976 Standout
Cyanotic congenital heart disease: Hematologic management
1991
Clonal origin of human tumors
1976
The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation.
1990 StandoutNobel
Platelet Physiology and Abnormalities of Platelet Function
1975 Standout
Platelet Physiology and Abnormalities of Platelet Function
1975
Plasmic degradation of bovine fibrinogen and non-cross-linked fibrins in solution and in gel form
1975
Bone marrow transplantation for acute myelosclerosis
1981 StandoutNobel
Works of H. Ekert being referenced
High incidence of cardiomyopathy in children treated with adriamycin and DTIC in combination chemotherapy.
1977
Hemophagocytic reticulosisA case report with investigations of immune and white cell function
1975
Prevention of cyclophosphamide/cytarabine-induced emesis with ondansetron in children with leukemia.
1990
Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy
2006
Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction
1994
Cognitive and academic outcome following cranial irradiation and chemotherapy in children: a longitudinal study
2000
Risk factors for intellectual and educational sequelae of cranial irradiation in childhood acute lymphoblastic leukaemia
1996
Neurobehavioural sequelae following cranial irradiation and chemotherapy in children: an analysis of risk factors
1997
Experience with Recombinant Factor VIla in Australia and New Zealand
1996
Hemostasis in cyanotic congenital heart disease
1970
Deep vein thrombosis in association with a circulating endogenous anticoagulant
1982
Evidence for the Clonal Origin of Chronic Myeloid Leukemia From a Sex Chromosome Mosaic: Clinical, Cytogenetic, and Marrow Culture Studies
1974
Evaluation of a New Concentrate for the Treatment of Factor IX Deficiency
1969
Platelet Release Abnormality and Reduced Prothrombin Levels in Children with Cyanotic Congenital Heart Disease
1977
INTRAVASCULAR COAGULATION IN GENERALIZED HERPES SIMPLEX INFECTION OF THE NEWBORN
1969
HEPARIN THERAPY IN THE HÆMOLYTIC-URÆMIC SYNDROME
1969
A randomized study of intermittent chemotherapy with or without BCG inoculation in maintenance therapy of childhood ALL
1980
Properties of post-infusion factor VIII in Von Willebrand's disease
1974
MARROW FUNCTION RECONSTITUTION BY FRACTION 3 OF PERCOLL-DENSITY-GRADIENT-SEPARATED CELLS
1986
Plasmin Lysis of Fibrinogen and Fibrin and the Antigenic Properties of their Degradation Products
1972
METHOTREXATE‐INDUCED CONGENITAL MALFORMATIONS
1971
COEXISTENT T-CELL LYMPHOBLASTIC LYMPHOMA AND AN ATYPICAL MYELOPROLIFERATIVE DISORDER ASSOCIATED WITH t(8;13)(p21;q14)
1997
Streptokinase and anti-thrombotic therapy in the hemolytic-uremic syndrome
1974
INTRAVENOUS IMMUNOGLOBULIN VERSUS ORAL CORTICOSTEROIDS IN ACUTE IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOOD
1985
POOR OUTLOOK FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA WITH RELAPSE
1979